205 related articles for article (PubMed ID: 29613885)
1. Hormone therapy in menopausal women with fibroids: is it safe?
Srinivasan V; Martens MG
Menopause; 2018 Aug; 25(8):930-936. PubMed ID: 29613885
[TBL] [Abstract][Full Text] [Related]
2. [The effects of menopausal replacement therapy in women with uterine myomas].
Orsini G; Pinto V; Di Biase S; D'Altorio C; Lanzilotti G
Minerva Ginecol; 1999 Nov; 51(11):421-5. PubMed ID: 10726441
[TBL] [Abstract][Full Text] [Related]
3. The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.
Sener AB; Seçkin NC; Ozmen S; Gökmen O; Doğu N; Ekici E
Fertil Steril; 1996 Feb; 65(2):354-7. PubMed ID: 8566261
[TBL] [Abstract][Full Text] [Related]
4. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Deng L; Wu T; Chen XY; Xie L; Yang J
Cochrane Database Syst Rev; 2012 Oct; 10():CD005287. PubMed ID: 23076912
[TBL] [Abstract][Full Text] [Related]
5. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Lethaby AE; Vollenhoven BJ
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
[TBL] [Abstract][Full Text] [Related]
6. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
7. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Wu T; Chen X; Xie L
Cochrane Database Syst Rev; 2007 Oct; (4):CD005287. PubMed ID: 17943846
[TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Lingxia X; Taixiang W; Xiaoyan C
Cochrane Database Syst Rev; 2007 Apr; (2):CD005287. PubMed ID: 17443581
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
10. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.
Moro E; Degli Esposti E; Borghese G; Manzara F; Zanello M; Raimondo D; Gava G; Arena A; Casadio P; Meriggiola MC; Seracchioli R
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480288
[No Abstract] [Full Text] [Related]
12. Medical management of fibroids.
Sankaran S; Manyonda IT
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
14. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
15. Does raloxifene inhibit the growth of uterine fibroids?
Palomba S; Zullo F; Orio F; Lombardi G
Fertil Steril; 2004 Jun; 81(6):1719-20; author reply 1720-1. PubMed ID: 15193512
[No Abstract] [Full Text] [Related]
16. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
17. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
18. Emerging hormonal treatments for menopausal symptoms.
Genazzani AR; Komm BS; Pickar JH
Expert Opin Emerg Drugs; 2015 Mar; 20(1):31-46. PubMed ID: 25557757
[TBL] [Abstract][Full Text] [Related]
19. What do TSECs provide in the menopausal hormone therapy?
Llaneza P; Calaf J; Jurado AR; Mendoza N; Otero B; Quereda F; Sánchez-Borrego R; Lubian D
Gynecol Endocrinol; 2018 Oct; 34(10):826-832. PubMed ID: 29790381
[TBL] [Abstract][Full Text] [Related]
20. Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.
Ang WC; Farrell E; Vollenhoven B
Climacteric; 2001 Dec; 4(4):284-92. PubMed ID: 11770184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
